Published in Ann Oncol on October 01, 2004
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies | NCT00703170
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55
Targeting the mTOR signaling network for cancer therapy. J Clin Oncol (2009) 4.52
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest (2011) 3.00
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Res (2008) 1.94
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy. J Hematol Oncol (2009) 1.70
A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma. Oral Oncol (2013) 1.57
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother (2009) 1.33
Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br J Cancer (2007) 1.22
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19
PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. Br J Cancer (2007) 1.09
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res (2010) 1.03
Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future Directions. Breast Cancer (Auckl) (2013) 1.02
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat (2013) 0.99
RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation. Cell Res (2013) 0.98
Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer. World J Clin Oncol (2014) 0.97
Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations. Br J Pharmacol (2014) 0.96
Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer. Biochim Biophys Acta (2014) 0.96
Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression. Oncoimmunology (2012) 0.93
Targeted therapies for ER+/HER2- metastatic breast cancer. BMC Med (2015) 0.91
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy. Adv Enzyme Regul (2008) 0.89
The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients. Cancer Biol Ther (2012) 0.89
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. Nat Commun (2014) 0.87
Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review). Int J Oncol (2012) 0.86
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. Oncotarget (2016) 0.86
New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma. Cancer (2011) 0.85
Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae. Neoplasia (2015) 0.83
Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy. Future Oncol (2010) 0.82
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition. Cancer Res (2013) 0.81
The molecular genetics of breast cancer and targeted therapy. Biologics (2007) 0.81
Potential of casein kinase I in digestive cancer screening. World J Gastrointest Oncol (2009) 0.79
Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy. J Cancer Res Clin Oncol (2010) 0.78
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Cancer Gene Ther (2011) 0.78
AKT activation controls cell survival in response to HDAC6 inhibition. Cell Death Dis (2016) 0.78
Loss of PTEN function may account for reduced proliferation pathway sensitivity to LY294002 in human prostate and bladder cancer cells. J Cancer Res Clin Oncol (2008) 0.76
PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. Oncotarget (2016) 0.75
Neomorphic mutations create therapeutic challenges in cancer. Oncogene (2016) 0.75
Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification. Front Vet Sci (2017) 0.75
Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. J Natl Cancer Inst (1999) 2.58
Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer. J Clin Oncol (1997) 2.28
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res (2000) 1.86
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Br J Cancer (2013) 1.85
Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol (2001) 1.73
Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res (2001) 1.69
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol (1998) 1.68
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther (2008) 1.61
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol (2003) 1.61
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J Clin Oncol (2000) 1.57
Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann Oncol (1998) 1.51
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol (1999) 1.35
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res (1999) 1.28
Progress in the development and acquisition of anticancer agents from marine sources. Ann Oncol (2003) 1.26
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG). Eur J Cancer (2003) 1.24
Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br J Cancer (2007) 1.22
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. Br J Cancer (2010) 1.21
Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum (2001) 1.17
Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene. Virology (2001) 1.16
Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses. J Gen Virol (1994) 1.10
Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol (1999) 1.09
NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol (2004) 1.08
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. J Antimicrob Chemother (1999) 1.06
Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem (2000) 1.06
Identification in porcine faeces of a novel virus with a bisegmented double stranded RNA genome. Arch Virol (1991) 1.03
Cryopreservation of varicella-zoster virions without loss of structural integrity or infectivity. Intervirology (1981) 1.02
Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology (1982) 1.01
Extrahepatic expression of plasma protein genes during inflammation. Inflammation (1991) 1.01
Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell. J Virol (1986) 1.00
Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy. Ann Oncol (2010) 1.00
Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infect Immun (1981) 0.99
A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1. Mol Cell Biol (2001) 0.98
Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res (2000) 0.98
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD). Crit Rev Oncol Hematol (2009) 0.97
Purification and molecular anatomy of the varicella-zoster virion. Biken J (1983) 0.96
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC). Br J Cancer (2013) 0.96
Monoclonal antibodies to the VP6 of porcine subgroup I rotaviruses reactive with subgroup I and non-subgroup I non-subgroup II strains. J Gen Virol (1990) 0.96
Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene (2012) 0.95
Diaphragmatic or transdiaphragmatic thoracic involvement in hepatic hydatid disease: surgical trends and classification. World J Surg (1995) 0.94
MBP-1 physically associates with histone deacetylase for transcriptional repression. Biochem Biophys Res Commun (1999) 0.94
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib. Clin Pharmacol Ther (2007) 0.94
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs (1997) 0.93
Characterization of PacMetUT1, a recently isolated human prostate cancer cell line. Prostate (2008) 0.92
Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab Invest (1995) 0.92
Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing. J Biol Chem (1990) 0.92
Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours. Ann Oncol (2000) 0.91
Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. J Virol (1984) 0.91
Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours. J Cancer Res Clin Oncol (2000) 0.90
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients. World J Urol (2011) 0.90
Analytical approaches for Hg determination in wastewater samples by means of total reflection X-ray fluorescence spectrometry. Talanta (2010) 0.89
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties. J Clin Oncol (2001) 0.89
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers. Clin Transl Oncol (2013) 0.88
Analysis of inlet and outlet industrial wastewater effluents by means of benchtop total reflection X-ray fluorescence spectrometry. Chemosphere (2010) 0.88
Assessment of metal availability to vegetation (Betula pendula) in Pb-Zn ore concentrate residues with different features. Environ Pollut (2006) 0.87
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001). Cancer Chemother Pharmacol (2014) 0.87
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis. Br J Cancer (2012) 0.87
Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay. Oncogene (2008) 0.87
Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains. Arch Virol (1996) 0.86
PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene (1999) 0.86
Development of novel and sensitive methods for the determination of sulfide in aqueous samples by hydrogen sulfide generation-inductively coupled plasma-atomic emission spectroscopy. Anal Chim Acta (2008) 0.86
Incidence and predisposing factors for incisional hernia in patients with liver transplantation. Hernia (2001) 0.86
Human alpha 2-HS-glycoprotein/bovine fetuin homologue in mice: identification and developmental regulation of the gene. Biochim Biophys Acta (1992) 0.85
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Ann Oncol (2013) 0.84
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer. Ann Oncol (2007) 0.84
Chromosomal localization of the human gene encoding c-myc promoter-binding protein (MPB1) to chromosome 1p35-pter. Genomics (1997) 0.84
Lead isotope ratio measurements by ICP-QMS to identify metal accumulation in vegetation specimens growing in mining environments. Sci Total Environ (2006) 0.83
Recall pneumonitis during systemic treatment with sunitinib. Ann Oncol (2010) 0.83
Results of the 2003-2004 GEP-ISFG collaborative study on mitochondrial DNA: focus on the mtDNA profile of a mixed semen-saliva stain. Forensic Sci Int (2005) 0.83
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res (1996) 0.83
Monitoring of nutrients, pesticides, and metals in waters, sediments, and fish of a wetland. Arch Environ Contam Toxicol (2006) 0.83
Identification of sperm subpopulations in canine ejaculates: effects of cold storage and egg yolk concentration. Anim Reprod Sci (2011) 0.81
A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Invest New Drugs (2012) 0.81
[Incidence and surgical treatment of extrahepatic abdominal hydatidosis]. Rev Esp Enferm Dig (1992) 0.81
The Memphis State University rubella outbreak. An example of changing rubella epidemiology. JAMA (1974) 0.81
Seroprevalence to bovine virus diarrhoea virus and other viruses of the bovine respiratory complex in Venezuela (Apure State). Prev Vet Med (1999) 0.81
[Surgical treatment of hepatolithiasis. Presentation of a case]. Rev Esp Enferm Dig (1998) 0.81
The Shouldice herniorrhaphy in the treatment of inguinal hernias: a prospective study on 775 patients. Hernia (2003) 0.80
Regulation of transferrin gene expression during lung development and injury. Am J Physiol (1997) 0.80
Molecular basis of colorrectal cancer: towards an individualized management? Rev Esp Enferm Dig (2011) 0.80
Cryopreservation of goat spermatozoa: comparison of two freezing extenders based on post-thaw sperm quality and fertility rates after artificial insemination. Theriogenology (2007) 0.80
Tissue specific expression of mouse transferrin during development and aging. Mech Ageing Dev (1990) 0.80
Importance of family history in colorectal cancer clinical practice. Colorectal Dis (2010) 0.80
Cellular expression of ceruloplasmin in baboon and mouse lung during development and inflammation. Am J Respir Cell Mol Biol (1996) 0.80
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies. J Clin Oncol (2000) 0.79
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer. Ann Oncol (1998) 0.79
The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy. J Endocrinol Invest (2011) 0.79
Assessment of goat semen freezability according to the spermatozoa characteristics from fresh and frozen samples. Anim Reprod Sci (2008) 0.78
Effect of endotoxin treatment on prostaglandin metabolism by rabbit uterus and oviduct. J Reprod Fertil (1980) 0.78
Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features. Clin Transl Oncol (2012) 0.78
Ventricular arrhythmias with conventional and liposomal amphotericin. Lancet (1993) 0.78
The effect of cryopreservation on goat semen characteristics related to sperm freezability. Anim Reprod Sci (2010) 0.78
Mitochondrial distribution and meiotic progression in canine oocytes during in vivo and in vitro maturation. Theriogenology (2010) 0.78